Patents by Inventor Mary Ruth Erickson

Mary Ruth Erickson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OBG3 globular head and uses thereof
    Patent number: 7671024
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. The application is related to OBG3 polypepide fragments and compositions comprising these fragments. It also discloses methods of reducing free fatty acid levels with the polypeptide fragments of the invention.
    Type: Grant
    Filed: May 23, 2008
    Date of Patent: March 2, 2010
    Assignee: Serono Genetics Institute S.A.
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen-Potin, Bernard Bihain
  • OBG3 Globular Head and Uses Thereof
    Publication number: 20090099076
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidermias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: May 23, 2008
    Publication date: April 16, 2009
    Applicant: Serono Genetics Institute S.A.
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen-Potin, Bernard Bihain
  • Isolated polypeptide comprising a leptin fragment
    Patent number: 7470669
    Abstract: The present invention is drawn to methods of screening for new compounds for the treatment of obesity and obesity-related diseases and disorders, as well as methods of treating obesity-related diseases and disorders, based on the discovery of the role of the leptin-LSR interaction in obesity.
    Type: Grant
    Filed: September 27, 2005
    Date of Patent: December 30, 2008
    Assignee: Serono Genetics Institute, S.A.
    Inventors: Frances Yen, Mary Ruth Erickson, Joachim Fruebis, Bernard Bihain
  • Nucleic acids encoding OBG3 polypeptides
    Patent number: 7393661
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. This application pertains to nucleic acids encoding a compound, globular OBG3 polypeptide fragments, vectors and transformed host cells containing these nucleic acids and methods of making the globular OBG3 polypeptide fragments.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: July 1, 2008
    Assignee: Serono Genetics Institute S.A.
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen-Potin, Bernard Bihain
  • Metabolic gene polynucleotides and polypeptides and uses thereof
    Patent number: 7348406
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Grant
    Filed: January 15, 2002
    Date of Patent: March 25, 2008
    Assignee: Serono Genetics Institute S.A.
    Inventors: Mary Ruth Erickson, Barbara A. Chicca, Bernard Bihain, Hiroaki Tanaka
  • Nucleic acids encoding OBG3 globular head and uses thereof
    Patent number: 7338787
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Grant
    Filed: October 20, 2004
    Date of Patent: March 4, 2008
    Assignee: Serono Genetics Institute S.A.
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen-Potin, Bernard Bihain
  • GMG-3 GMG-4 and GMG-6 polynucleotides and polypeptides and uses thereof
    Patent number: 7326678
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Grant
    Filed: January 15, 2002
    Date of Patent: February 5, 2008
    Assignee: Serono Genetics Institute S.A.
    Inventors: Mary Ruth Erickson, Barbara A. Chicca, Bernard Bihain, Hiroaki Tanaka, Tom Chu, Deno P. Dialynas, Aaron Scalia
  • Metabolic gene polynucleotides and polypeptides and uses thereof
    Publication number: 20060247160
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: January 15, 2002
    Publication date: November 2, 2006
    Applicant: Genset S.A.
    Inventors: Mary Ruth Erickson, Barbara Chicca, Bernard Bihain, Hiroaki Tanaka
  • OBG3 globular head and uses thereof
    Patent number: 6989367
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: January 24, 2006
    Assignee: Genset S.A.
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen-Potin, Bernard Bihain
  • OBG3 globular head and uses thereof for decreasing body mass
    Patent number: 6967091
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: November 22, 2005
    Assignee: Genset, S.A.
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen, Bernard Bihain
  • OBG3 globular head and uses thereof
    Publication number: 20040067881
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: November 1, 2002
    Publication date: April 8, 2004
    Applicant: Genset S.A.
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen-Potin, Bernard Bihain
  • OBG3 globular head and uses thereof for decreasing body mass
    Patent number: 6579852
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Grant
    Filed: July 19, 2001
    Date of Patent: June 17, 2003
    Assignee: Genset S.A.
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen-Potin, Bernard Bihain
  • OBG3 globular head and uses thereof for decreasing body mass
    Publication number: 20030100500
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: August 29, 2002
    Publication date: May 29, 2003
    Applicant: Genset S.A.
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen, Bernard Bihain
  • OBG3 globular head and uses thereof for decreasing body mass
    Patent number: 6566332
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Grant
    Filed: February 5, 2001
    Date of Patent: May 20, 2003
    Assignee: Genset S.A.
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen, Bernard Bihain
  • OBG3 globular head and uses thereof for decreasing body mass
    Publication number: 20020091080
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: July 19, 2001
    Publication date: July 11, 2002
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen-Potin, Bernard Bihain
  • OBG3 globular head and uses thereof for decreasing body mass
    Publication number: 20020058617
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: January 10, 2001
    Publication date: May 16, 2002
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen, Bernard Bihain
  • OBG3 globular head and uses thereof for decreasing body mass
    Publication number: 20020037849
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: February 5, 2001
    Publication date: March 28, 2002
    Inventors: Joachim Fruebis, Mary Ruth Erickson, Frances Yen, Bernard Bihain